Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Oxygen Enhanced MRI in Assessment of Malignant Brain Tumors

NCT05904704 is registered in ClinicalTrials.gov with OHSU Knight Cancer Institute as lead sponsor.

NCT NCT05904704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05904704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Oxygen Enhanced MRI in Assessment of Malignant Brain Tumors
Lead sponsor
OHSU Knight Cancer Institute
Phase
Not applicable
Overall status
Withdrawn
Start date
April 12, 2023
Completion date
March 31, 2029
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intracranial neoplasm